PubMed:15630069 / 2341-2597
Annnotations
LitCoin-entities
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| 1367 | 36-54 | DiseaseOrPhenotypicFeature | denotes | insulin resistance | MESH:D007333 |
| 1368 | 121-130 | ChemicalEntity | denotes | clozapine | MESH:D003024 |
| 1369 | 131-141 | ChemicalEntity | denotes | olanzapine | MESH:C076029 |
| 1370 | 142-153 | ChemicalEntity | denotes | risperidone | MESH:D018967 |
| 1371 | 156-165 | ChemicalEntity | denotes | clozapine | MESH:D003024 |
| 1372 | 169-180 | ChemicalEntity | denotes | risperidone | MESH:D018967 |
| 1373 | 206-216 | ChemicalEntity | denotes | olanzapine | MESH:C076029 |
| 1374 | 220-231 | ChemicalEntity | denotes | risperidone | MESH:D018967 |
LitCoin-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T18 | 0-256 | Sentence | denotes | The homeostasis model assessment of insulin resistance also differed significantly among groups (F(33) = 4.92; P = .01) (clozapine>olanzapine>risperidone) (clozapine vs risperidone, t(33) = 2.94; P = .006; olanzapine vs risperidone, t(33) = 2.42; P = .02). |
LitCoin-GeneOrGeneProduct-v0
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T28 | 36-43 | GeneOrGeneProduct | denotes | insulin |
| T29 | 196-204 | GeneOrGeneProduct | denotes | P = .006 |
LitCoin-GeneOrGeneProduct-v2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T16 | 36-43 | GeneOrGeneProduct | denotes | insulin |
LitCoin-Disease-MeSH
| Id | Subject | Object | Predicate | Lexical cue | originalLabel |
|---|---|---|---|---|---|
| T12 | 36-54 | DiseaseOrPhenotypicFeature | denotes | insulin resistance | D007333 |
LitCoin-MeSH-Disease-2
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T12 | 36-54 | DiseaseOrPhenotypicFeature | denotes | insulin resistance | D007333 |
LitCoin-MONDO_bioort2019
| Id | Subject | Object | Predicate | Lexical cue | #label |
|---|---|---|---|---|---|
| T10 | 36-54 | DiseaseOrPhenotypicFeature | denotes | insulin resistance | D007333 |
LitCoin-Chemical-MeSH-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T77 | 121-130 | ChemicalEntity | denotes | clozapine | D003024|http://purl.obolibrary.org/obo/CHEBI_3766 |
| T79 | 131-141 | ChemicalEntity | denotes | olanzapine | D000077152|http://purl.obolibrary.org/obo/CHEBI_7735 |
| T81 | 142-153 | ChemicalEntity | denotes | risperidone | D018967|http://purl.obolibrary.org/obo/CHEBI_8871 |
| T83 | 156-165 | ChemicalEntity | denotes | clozapine | D003024|http://purl.obolibrary.org/obo/CHEBI_3766 |
| T85 | 169-180 | ChemicalEntity | denotes | risperidone | D018967|http://purl.obolibrary.org/obo/CHEBI_8871 |
| T87 | 206-216 | ChemicalEntity | denotes | olanzapine | D000077152|http://purl.obolibrary.org/obo/CHEBI_7735 |
| T89 | 220-231 | ChemicalEntity | denotes | risperidone | D018967|http://purl.obolibrary.org/obo/CHEBI_8871 |
LitCoin-training-merged
| Id | Subject | Object | Predicate | Lexical cue | #label | ID: |
|---|---|---|---|---|---|---|
| T89 | 220-231 | ChemicalEntity | denotes | risperidone | http://purl.obolibrary.org/obo/CHEBI_8871|D018967 | |
| T87 | 206-216 | ChemicalEntity | denotes | olanzapine | http://purl.obolibrary.org/obo/CHEBI_7735|D000077152 | |
| T85 | 169-180 | ChemicalEntity | denotes | risperidone | http://purl.obolibrary.org/obo/CHEBI_8871|D018967 | |
| T83 | 156-165 | ChemicalEntity | denotes | clozapine | http://purl.obolibrary.org/obo/CHEBI_3766|D003024 | |
| T81 | 142-153 | ChemicalEntity | denotes | risperidone | http://purl.obolibrary.org/obo/CHEBI_8871|D018967 | |
| T79 | 131-141 | ChemicalEntity | denotes | olanzapine | http://purl.obolibrary.org/obo/CHEBI_7735|D000077152 | |
| T77 | 121-130 | ChemicalEntity | denotes | clozapine | http://purl.obolibrary.org/obo/CHEBI_3766|D003024 | |
| T91158 | 36-54 | DiseaseOrPhenotypicFeature | denotes | insulin resistance | D007333 |